Medications for Opioid Use Disorder — A Toolkit for Improving Practice — TIP 63, Part 2
Please join us for this two-part QC “Caring for ME” webinar series that will introduce SAMHSA’s recently-developed national guidelines, “TIP-63, Guidelines on the Use of Medications for Opioid Use Disorder” (also known as Medications for Addiction Treatment, or MAT). In the face of the still-growing epidemic of opioid use and overdose deaths, more clinicians are stepping up to offer medications for OUD in a range of practice settings, but often face questions about the specifics of treatment. These national guidelines offer evidence-based standards of care and are a “must-have” tool for clinicians providing these medications.
- Understand SAMHSAs goals, purpose for developing TIP63, Medications for OUD
- Describe general principles, approach to use of medications for OUD
- Understand indications, goals, key treatment principles for using methadone for OUD treatment
Michelle Lofwall, M.D., DFASSAM
Associate Professor of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, University of Kentucky College of Medicine
Dr. Lofwall is board-certified in psychiatry and addiction medicine and serves as Associate Professor in the Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Chair at the University of Kentucky College of Medicine. She serves as the medical director of the Robert Straus Clinic and the First Bridge Clinic within the Center on Drug and Alcohol Research, providing treatment to those suffering from substance use disorders. She is an accomplished researcher with more than 70 publications and cited works. Dr. Lowfall serves on the board the American Society of Addiction Medicine (ASAM), and was one of the developers of SAMHSA’s TIP-63 Guidelines on the use of Medications for Opioid Use Disorder.
Feb. 5, 2019, 12:00pm-1:00pm EST